Omada Health (OMDA) quarterly income statement — complete revenue, gross profit & net income history
Omada Health (OMDA) annual income statement — 4-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q1'24 |
|---|
| Sales/Revenue | 87.83M | 78.05M | 75.85M | 68.03M | 61.37M | 54.96M | 35.09M |
| Revenue Growth % | 43.12% | 42% | - | - | - | 56.61% | - |
| Cost of Goods Sold | 24.05M | 29.36M | 22.18M | 22.96M | 21.19M | 23.06M | 17.75M |
| COGS % of Revenue | 27.38% | 37.61% | 29.25% | 33.75% | 34.53% | 41.96% | 50.57% |
| Gross Profit | 63.79M | 48.69M | 53.66M | 45.07M | 40.18M | 31.9M | 17.35M |
| Gross Margin % | 72.62% | 62.39% | 70.75% | 66.25% | 65.47% | 58.04% | 49.43% |
| Gross Profit Growth % | 58.76% | 52.64% | - | - | - | 83.88% | - |
| Operating Expenses | 60.24M | 53.47M | 50.38M | 47.58M | 44.52M | 40.3M | 35.34M |
| OpEx % of Revenue | 68.58% | 68.51% | 66.43% | 69.95% | 72.55% | 73.31% | 100.7% |
| Selling, General & Admin | 45.61M | 3.41M | 38.83M | 37.28M | 34.52M | 31.49M | 26.45M |
| SG&A % of Revenue | 51.93% | 4.37% | 51.19% | 54.8% | 56.25% | 57.29% | 75.35% |
| Research & Development | 14.63M | 739K | 11.55M | 10.3M | 10M | 8.81M | 8.9M |
| R&D % of Revenue | 16.65% | 0.95% | 15.23% | 15.14% | 16.3% | 16.02% | 25.35% |
| Other Operating Expenses | 0 | 1000K | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 3.55M | -4.78M | 3.28M | -2.51M | -4.34M | -8.4M | -17.99M |
| Operating Margin % | 4.04% | -6.13% | 4.33% | -3.69% | -7.08% | -15.28% | -51.27% |
| Operating Income Growth % | 181.7% | 43.06% | - | - | - | 53.34% | - |
| EBITDA | 6.64M | -3.27M | 4.73M | -1.15M | -2.99M | -7.06M | -16.87M |
| EBITDA Margin % | 7.56% | -4.19% | 6.23% | -1.7% | -4.88% | -12.85% | -48.06% |
| EBITDA Growth % | 321.86% | 53.66% | - | - | - | 58.13% | - |
| D&A (Non-Cash Add-back) | 3.09M | 1.51M | 1.45M | 1.36M | 1.35M | 1.33M | 1.13M |
| EBIT | 5.31M | -2.95M | 5.17M | -3.18M | -4.22M | -8.37M | -17.84M |
| Net Interest Income | 1.75M | 1.81M | 1.88M | 1.66M | -231K | -532K | -601K |
| Interest Income | 1.76M | 1.83M | 1.89M | 2.01M | 863K | 542K | 529K |
| Interest Expense | 14K | 18K | 13K | 353K | 1.09M | 1.07M | 1.13M |
| Other Income/Expense | 1.75M | 1.81M | 1.88M | -665K | -967K | -1.05M | -976K |
| Pretax Income | 5.29M | -2.97M | 5.16M | -3.18M | -5.31M | -9.45M | -18.97M |
| Pretax Margin % | 6.03% | -3.81% | 6.8% | -4.67% | -8.65% | -17.19% | -54.05% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 5.29M | -2.97M | 5.16M | -3.18M | -5.31M | -9.45M | -18.97M |
| Net Margin % | 6.03% | -3.81% | 6.8% | -4.67% | -8.65% | -17.19% | -54.05% |
| Net Income Growth % | 199.68% | 68.56% | - | - | - | 50.19% | - |
| Net Income (Continuing) | 5.29M | -2.97M | 5.16M | -3.18M | -5.31M | -9.45M | -18.97M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.08 | -0.05 | 0.09 | -0.05 | -0.09 | -0.17 | -0.34 |
| EPS Growth % | 186.39% | 70.35% | - | - | - | 50% | - |
| EPS (Basic) | 0.09 | -0.05 | 0.09 | -0.06 | -0.09 | -0.17 | -0.34 |
| Diluted Shares Outstanding | 63.95M | 58.92M | 58.43M | 57.66M | 57.32M | 55.74M | 55.74M |
| Basic Shares Outstanding | 59.69M | 58.92M | 58.43M | 52.97M | 57.32M | 55.74M | 55.74M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |